Drugs & Side Effects | Cancer Drugs

Fosamax News

Fosamax Implicated in Jawbone Erosion

RSS News Feeds
Drugs & Pharmacuticals
Osteonecrosis of the Jaw (ONJ)
Fosamax
 All RSS Feeds

At a glance:

The drug maker Merck has yet another lawsuit to contend with, this time over its osteoporosis medication Fosamax. 
 
A class of patients in Florida alleges that they developed osteonecrosis of the jaw, a rare but painful and debilitating condition, as a result of Fosamax treatment and that Merck was negligent in disclosing the risk. 
 
Merck claims that this side effect did not appear in its clinical trials, but did alter its labelling to include it in 2005.

Merck in court over osteoporosis drug

New Scientist - 4/19/2006 2:42 PM

THE drugs giant Merck may need to hire yet more lawyers. Already facing lawsuits from thousands of patients who blame their heart disease on the painkiller Vioxx, Merck is now battling claims that its osteoporosis drug Fosamax can erode the jawbones.
 
Tim O'Brien, an attorney in Pensacola, Florida, has filed a suit on behalf of 250 patients who developed osteonecrosis of the jaw after taking Fosamax. In this condition, diminished blood supply causes bone to die
 
· Read The Full Fosamax Article From New Scientist -->

· Read All Fosamax (Alendronate) News Stories -->

Comments On Fosamax News Articles:


No Current Comments
Posted by Admin on 3/20/2006

There are no current comments. Why not post one?

Leave a Comment:

Once you click the 'Save Comment' button, you will receive a verification email from our website. Be sure to change any spam settings to allow webmaster@lawsuitsearch.com as a trusted sender.
 
If you are already a member, you can Sign In Here.
 
You can create your own FREE user account that you can use to participate in our message boards, blogs, newsletters and other community activities such as this one. To get your FREE user account, click here.

Email Address:

Your Name:

Message Title:

Message: